Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 8/2016

01-08-2016 | Commentary

Left behind: cancer disparities in the developed world

Authors: Niharika Dixit, Gregory B. Crawford, Manon Lemonde, Cynthia N. Rittenberg, Paz Fernández-Ortega

Published in: Supportive Care in Cancer | Issue 8/2016

Login to get access

Abstract

Huge advances have been made in cancer treatments over recent decades; however, significant disparities still exist in the developed world on the basis of race, socioeconomic status, education level, geographical location, and immigration status and in the United States, insurance status. Cancer disparities persist in the continuum of cancer care from risk factors, screening, diagnosis, treatment, survivorship, and end-of-life care. The causes of disparities are complex and multifactorial. The MASCC (Multinational Association of Supportive Care in Cancer) Education Study Group would like to propose a framework of cancer disparities from a social perspective utilizing “social determinants of health” as delineated by the World Health Organization and highlight an unmet need for research and policy innovations to address cancer disparities in developed world.
Literature
1.
Duffy S, Richards M, Selby P, Lawler M (2013) Addressing cancer disparities in Europe: a multifaceted problem that requires interdisciplinary solutions. Oncologist 18(12):e29–e30CrossRefPubMedPubMedCentral
2.
Albano JD, Ward E, Jemal A, et al. (2007) Cancer mortality in the United States by education level and race. J Natl Cancer Inst 99(18):1384–1394CrossRefPubMed
3.
Aizer AA, Wilhite TJ, Chen MH, et al. (2014) Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer 120(10):1532–1539CrossRefPubMed
4.
Byers TE, Wolf HJ, Bauer KR, et al. (2008) The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care study. Cancer 113(3):582–591
5.
Chong A, Roder D (2010) Exploring differences in survival from cancer among Indigenous and non-Indigenous australians: Implications for health service delivery and research. Asian Pac J Cancer Prev 11(4):953–961PubMed
6.
Zeng C, Wen W, Morgans AK, Pao W, Shu XO, Zheng W (2015) Disparities by race, age, and sex in the improvement of survival for major cancers: results from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program in the United States, 1990 to 2010. JAMA Oncol 1(1):88–96
7.
8.
Fiscella K, Franks P, Meldrum S (2004) Estimating racial/ethnic disparity in mammography rates: It all depends on how you ask the question. Prev Med 39(2):399–403
9.
Mullins CD, Blatt L, Gbarayor CM, Yang HW, Baquet C (2005) Health disparities: A barrier to high-quality care. Am J Health Syst Pharm 62(18):1873–1882CrossRefPubMedPubMedCentral
10.
Abdollah F, Sammon JD, Majumder K, et al. (2015) Racial disparities in end-of-life care among patients with prostate cancer: a population-based study. J Natl Compr Cancer Netw 13(9):1131–1138
11.
Australian Institute of Health and Welfare (2011) Cancer in Australia: Actual incidence and mortality data from 1982 to 2007 and projections to 2010. Asia Pac J Clin Oncol 7(4):325–338CrossRef
12.
Cunningham J, Rumbold AR, Zhang X, Condon JR (2008) Incidence, aetiology, and outcomes of cancer in Indigenous peoples in Australia. Lancet Oncol 9(6):585–595CrossRefPubMed
13.
Patel MI, Schupp CW, Gomez SL, Chang ET, Wakelee HA (2013) How do social factors explain outcomes in non-small-cell lung cancer among Hispanics in california? explaining the Hispanic paradox. J Clin Oncol 31(28):3572–3578CrossRefPubMedPubMedCentral
14.
Survival of cancer patients in Europe: The EUROCARE-2 study. IARC Sci Publ. 1999;(151)(151):1–572.
15.
Abdel-Rahman M, Stockton D, Rachet B, Hakulinen T, Coleman MP (2009) What if cancer survival in Britain were the same as in Europe: How many deaths are avoidable? Br J Cancer 101(Suppl 2):S115–S124CrossRefPubMedPubMedCentral
16.
Dumont DM, Allen SA, Brockmann BW, Alexander NE, Rich JD (2013) Incarceration, community health, and racial disparities. J Health Care Poor Underserved 24(1):78–88CrossRefPubMed
17.
Flores YN, Davidson PL, Nakazono TT, Carreon DC, Mojica CM, Bastani R. Neighborhood socio-economic disadvantage and race/ethnicity as predictors of breast cancer stage at diagnosis. BMC Public Health. 2013;13:1061–2458-13-1061.
18.
Busch EL, Martin C, DeWalt DA, Sandler RS (2015) Functional health literacy, chemotherapy decisions, and outcomes among a colorectal cancer cohort. Cancer Control 22(1):95–101PubMedPubMedCentral
19.
Shariff-Marco S, Yang J, John EM, et al. (2014) Impact of neighborhood and individual socioeconomic status on survival after breast cancer varies by race/ethnicity: The neighborhood and breast cancer study. Cancer Epidemiol Biomark Prev 23(5):793–811CrossRef
20.
Polite BN (2015) States as the laboratory for democracy: Is anybody paying attention, and does anybody care? J Clin Oncol 33(8):815–816CrossRefPubMed
21.
Braun KL, Tsark J, Santos LA, Abrigo L (2003) Native Hawaiian Cancer Awareness Research and Training Network. ‘Imi hale—the Native Hawaiian cancer awareness, research, and training network: second-year status report. Asian Am Pac Isl J Health 10(1):4–16PubMedPubMedCentral
22.
Victor RG, Ravenell JE, Freeman A, et al. (2011) Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial. Arch Intern Med 171(4):342–350CrossRefPubMed
Metadata
Title
Left behind: cancer disparities in the developed world
Authors
Niharika Dixit
Gregory B. Crawford
Manon Lemonde
Cynthia N. Rittenberg
Paz Fernández-Ortega
Publication date
01-08-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 8/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3192-4

Other articles of this Issue 8/2016

Supportive Care in Cancer 8/2016 Go to the issue

Commentary

From normal response to clinical problem: definition and clinical features of fear of cancer recurrence

Review Article

Unmet care needs in people living with advanced cancer: a systematic review

Original Article

Cancer and fertility preservation in Puerto Rico: a qualitative study of healthcare provider perceptions

Original Article

Adherence to treatment guidelines for cancer-associated thrombosis: a French hospital-based cohort study

Original Article

The trajectory of neurotoxic side effects’ impact on daily life: a qualitative study

Letter to the editor

Comment on “Linfotaping with kinesio® tape to manage and treat lymphedema patients: safety and tolerability are more important the efficacy?”
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits